Tetra Bio-Pharma receives Health Canada Phase 3 clinical trial approval for smokable dried cannabis prescription drug. Tetra Bio-Pharma Inc., a cannabinoid-based drug development and discovery company, has received a No Objection Letter (NOL) from the Therapeutic Products Directorate (TPD) Health Canada to its clinical trial application (CTA) for the company’s PPP001 prescription smokable dried cannabis product. Coinciding with World Cancer Day 2018, Tetra…